AUM: $5 billion
Formed in 2009, TLG Africa Limited is a permanent capital investment vehicle focusing on equity opportunities in Sub-Saharan Africa (SSA).
Investments include direct minority/majority stake investments, secondary opportunities and distressed fund restructurings. TLG Africa always seeks board representation, along with other minority protections.
Notable investments include WHO pre-approved pharmaceutical plant QCIL (Uganda) and healthcare facilities in West Africa. In recognition for our efforts, our deals have won multiple awards including ‘Landmark Deal of the Decade’ in 2012 and ‘Frontier Deal of the Year’ in 2014 from Private Equity Africa.
Areas of expertise